How big pharma and startups can learn from each otherFrancesca Wuttke’s varied career has taken her from research roles to private equity and now to the role Share XHow big pharma and startups can learn from each otherhttps://deep-dive.pharmaphorum.com/magazine/digital-health/almriall-startups-francesca-wuttke-digital/
Where next for patient centricity in pharma?As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need Share XWhere next for patient centricity in pharma?https://pharmaphorum.com/views-analysis-patients/where-next-for-patient-centricity-in-pharma/
Comms from the ground upDavid Hunt’s career has taken him from painting Havas Lynx Group’s offices to running the agency, and now Share XComms from the ground uphttps://deep-dive.pharmaphorum.com/magazine/sales-and-marketing-2019/comms-from-the-ground-up-david-hunt-havas/
Does the big pharma monster need taming?Paul Tunnah reviews Hedley Rees’ ‘Taming the Big Pharma Monster: by Speaking Truth to Power’, which takes pharma Share XDoes the big pharma monster need taming?https://pharmaphorum.com/views-analysis-sales-marketing/does-the-big-pharma-monster-need-taming/
The real conspiracy in the pharma industryPaul Tunnah on how pharma industry workers can negatively affect patients without even realising it. If you work Share XThe real conspiracy in the pharma industryhttps://pharmaphorum.com/views-and-analysis/the-real-conspiracy-pharma-industry/
Building a new type of pharmaceutical company – a vision for pharma 2.0The definition of healthcare has become incredibly diverse since the turn of the century. It feels like it Share XBuilding a new type of pharmaceutical company – a vision for pharma 2.0https://pharmaphorum.com/views-analysis-sales-marketing/building-new-pharmaceutical-company-pharma-2-0/
Let’s talk about drugsPaul Tunnah asks if we need to rethink pharma’s strict marketing regulations and have a discussion on how Share XLet’s talk about drugshttps://pharmaphorum.com/views-and-analysis/lets-talk-drugs/
Can ‘design thinking’ revolutionise pharma’s culture?As part of pharmaphorum’s ‘eye-on-innovation’ series, Paul Tunnah speaks to UCB’s head of innovation, Gregory Miller, about how Share XCan ‘design thinking’ revolutionise pharma’s culture?https://pharmaphorum.com/views-and-analysis/can-design-thinking-revolutionise-pharmas-culture/
Merck KGaA celebrates 350 years of innovationAs part of pharmaphorum’s eye-on-innovation interview series, Paul Tunnah speaks to Merck Biopharma’s vice president of innovation Ulrich Share XMerck KGaA celebrates 350 years of innovationhttps://pharmaphorum.com/views-analysis-digital/merck-kgaa-celebrates-350-years-innovation/
